首页> 美国卫生研究院文献>Neurologia medico-chirurgica >Treatment of Acute Cerebral Artery Occlusion Using the Penumbra System: Our Early Experience
【2h】

Treatment of Acute Cerebral Artery Occlusion Using the Penumbra System: Our Early Experience

机译:半影系统治疗急性脑动脉阻塞:我们的早期经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intravenous recombinant tissue-type plasminogen activator (rt-PA) therapy is highly recommended to patients who are diagnosed with ischemic stroke within 4.5 hours after the onset while mechanical clot retrieval can be attempted in patients who are not indicated for or cannot effectively receive intravenous rt-PA therapy. In this article, we report early treatment outcomes and discuss the usefulness of mechanical clot retrieval using the Penumbra system (Penumbra Inc., Alameda, California, USA), especially in terms of technical cautions during the procedure and adaptability to elderly and high National Institutes of Health Stroke Scale (NIHSS) patients. We included 7 patients with thromboembolic occlusion. Pre-treatment NIHSS score ranged from 11 to 36 (mean: 24.9). All patients achieved good recanalization [thrombolysis in cerebral infarction (TICI) grade 2a or greater] without complications. The NIHSS score at 30 days after the treatment ranged between 0 and 28 (mean: 12.4), and improved more than 10 points in 4 of the 7 patients (57.1%). To obtain good recanalization without complications, selection of suitable reperfusion catheter and careful manipulation of separator prefiguring the occluded distal vessels are essential. The improved NIHSS score at 30 days after the treatment may have led to favorable results, such as an increased participation in available rehabilitation programs and the alleviation of the burden of care. Our findings suggest that the Penumbra system might be effective for treatment in elderly patients or patients with high NIHSS score wherein rt-PA therapy is inadvisable or ineffective in ischemic stroke secondary to large vessel occlusion. Recanalization can improve their quality of life on condition that the procedure is performed successfully without serious complications.
机译:强烈建议在发病后4.5小时内诊断出患有缺血性中风的患者进行静脉内重组组织型纤溶酶原激活剂(rt-PA)治疗,而对于没有适应症或不能有效接受静脉rt治疗的患者,可以尝试机械凝块恢复-PA疗法。在本文中,我们报告了早期治疗的结果,并讨论了使用Penumbra系统(Penumbra Inc.,阿拉米达,加利福尼亚,美国)进行机械凝块恢复的有用性,特别是在手术过程中的技术注意事项以及对老年人和高等国家研究所的适应性方面健康中风量表(NIHSS)患者。我们纳入了7例血栓栓塞患者。治疗前NIHSS评分范围为11到36(平均24.9)。所有患者均实现了良好的再通[2a级或更高的脑梗死溶栓(TICI)],无并发症。治疗后30天的NIHSS评分在0到28之间(平均:12.4),在7例患者中有4例的NIHSS评分提高了10分以上(57.1%)。为了获得良好的再通气而无并发症,选择合适的再灌注导管和仔细操作隔离器以使阻塞的远端血管成形是必不可少的。治疗后30天NIHSS评分的改善可能带来了良好的结果,例如增加了对现有康复计划的参与并减轻了护理负担。我们的发现表明,半影半影系统对于老年患者或NIHSS评分高的患者可能有效,其中rt-PA治疗对于继发于大血管闭塞的缺血性卒中不建议或无效。在手术成功执行且无严重并发症的情况下,再通可以提高其生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号